Analysts on Wall Street project that Bausch + Lomb (BLCO) will announce quarterly earnings of $0.35 per share in its forthcoming report, representing an increase of 40% year over year. Revenues are ...

Is On Investors’ Radar Today Bausch Health Companies (NYSE:BHC) has drawn fresh attention after its recent share move, closing at $5.99, which comes against a month return of about 14% and a past 3 ...

Interestingly, Bausch Health shares started the year trending higher. However, not too long after that, the stock began to ...

At Bausch & Lomb, foundational AI learning is now mandatory. If employees don’t complete it, they’re not eligible for their ...

Drug companies Lannett and Bausch agreed to pay $18 million over alleged price-fixing as part of far-reaching lawsuits ...

Tanztheater Wuppertal’s dancers treat the audience like lovers in an entrancing show of seductive elegance ...

As Sweet Mambo is staged at the Edinburgh festival, Wim Wenders, music adviser Matthias Burkert and artists including Madeleine Peyroux reflect on Tanztheater Wuppertal’s eclectic soundtrack ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, issued the following statement ...

In 2007, Pina Bausch was preparing her company’s latest “city piece”, this one based on a visit to Kolkotta. But she was also ...

Bausch Health specializes in therapies to treat disorders in gastroenterology, hepatology, neurology, and dermatology. The deal with KKR will give it a lot more flexibility in its operations. In the ...

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's ...